SEC Filing Form 4: Officer and Director Stock Transaction

Michael DePasquale, Chief Executive Officer and Chairman of BIO-KEY INTERNATIONAL INC, acquired 250 shares of common stock on June 30, 2026, under the company's 2021 Employee Stock Purchase Plan. This acquisition was exempt from reporting under Rule 16b-3. The transaction price was $3.83 per share. Following this acquisition, Mr. DePasquale owns 10,778 shares. All share amounts have been adjusted to reflect a 1-for-10 reverse stock split effective April 30, 2026.